Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients

BACKGROUND: In premenopausal patients with human epidermal growth factor receptor 2 (HER2)–positive early breast cancer, the gonadotoxicity of trastuzumab and lapatinib remains largely uncertain, and the prognostic effect of treatment-related amenorrhea (TRA) is unknown. METHODS: In the Adjuvant Lap...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Lambertini, Matteo, Campbell, Christine, Bines, José, Korde, Larissa A, Izquierdo, Miguel, Fumagalli, Debora, Del Mastro, Lucia, Ignatiadis, Michail, Pritchard, Kathleen, Wolff, Antonio C, Jackisch, Christian, Lang, Istvan, Untch, Michael, Smith, Ian, Boyle, Frances, Xu, Binghe, Barrios, Carlos H, Baselga, José, Moreno-Aspitia, Alvaro, Piccart, Martine, Gelber, Richard D, de Azambuja, Evandro
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6335113/
https://ncbi.nlm.nih.gov/pubmed/29878225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djy094
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados